Tessara Therapeutics and Psylo

About Tessara Therapeutics and Psylo

Tessara Therapeutics focuses on converging innovation to break barriers in neurology by providing human-relevant 3D neural models. Their proprietary RealBrain® technology generates reproducible, scalable micro-tissues that mimic the complexity of the human brain, enabling reliable insights and confident decision-making in CNS drug discovery.

Products & Services

RealBrain® Technology:A proprietary platform for generating reproducible, scalable micro-tissues that mimic the human brain's complexity.

ArtiBrain™ - Healthy Human Brain Model:A model representing a healthy human brain baseline for neural function studies.

ADBrain™ - Alzheimer's Disease Model:A specialized model for studying Alzheimer's disease pathology.

Screening and Custom Model Development Services:Integrated services to support preclinical research and CNS drug discovery.

Specialties

3D Neural Models Human Brain Micro-Tissues CNS Drug Discovery Alzheimer's Disease Research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant (Cooperative Research Centres Projects - CRC-P) T: - FT: Grant (Cooperative Research Centres Projects - CRC-P)	A: 3000000 MR: - FA: $3 million FAN: 3000000	D: 2024-10-28 FD: 2024-10-28	1 investors

Grant (Cooperative Research Centres Projects - CRC-P) Latest

2024-10-28

$3.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Elias Pavlopoulos

Associate Director R&D, Regeneron Pharmaceuticals

J

Jennifer Elisseeff

Director, Translational Tissue Engineering Center, Johns Hopkins University

P

Phil Smith

Director

C

Christopher Boyer

Director

P

Paul Adlard

Chief Scientific Officer

G

Greg Collier

Chairman

View 9 more team members with Pro

Unlock Full Team Directory

Recent News